This year's dominant flu strain has a new name — subclade K variant — but scientists say there's good reason not to panic. The mutated form of influenza A (H3N2) is now driving the majority of flu cases across the United States this season, a development that initially raised concerns about a potential "super flu." Yet according to data from the U.S. Centers for Disease Control and Prevention, the spread of this variant has not resulted in more severe cases or deaths than in recent flu seasons. The virus has drifted, as viruses do, but our defenses have kept pace.
Influenza viruses mutate constantly. Every time the virus copies itself inside a host, there's a small chance of a genetic error — a mutation.ens of millions of people are infected with influenza in the United States alone each year, which means the virus has enormous opportunities to evolve as it moves through the population. Over time, enough mutations accumulate that the virus begins to look different from its ancestors. Scientists call this phenomenon viral drift, and it's precisely why annual flu shots exist: to help immune cells keep up with the shifting target.
"We're seeing a drift here, not a shift," explains Professor Alessandro Sette of the La Jolla Institute for Immunology. "The impact is much more limited." A shift occurs when a population encounters an entirely unfamiliar viral subgroup — one the immune system hasn't seen before. The 1918–1920 influenza pandemic, caused by an H1N1 avian influenza virus, was a shift: that H1N1 subtype had mutations that allowed it to largely evade human antibodies and immune cells. The subclade K variant is far less radical. it remains a member of the familiar influenza A (H3N2) family, and most people have encountered that family at some point in their lives. Vaccines also target it directly. In a study published in NEJM Evidence in March 2026, researchers reported that the 2025–2026 seasonal flu vaccine prompted many individuals to produce antibodies capable of recognizing the subclade K variant.
That said, vaccinated people can still get sick, and that's not a sign that the shots have failed.
"If you have a new viral variant and you experience mild symptomatology, that doesn't mean that the vaccine doesn't work," says LJI Research Assistant Professor Alba Grifoni. "The vaccine was designed to prevent you from having to go to the hospital." Thens: "The immune system has multiple ways to combat infection," Sette adds. "Even if a virus escapes our antibodies and causes infection, our immunity wall protects us from severe disease." That wall includes T cells, which recognize and destroy infected cells. "T cells can limit infection and limit severe disease," Sette says.
So while new variants will continue to emerge — the article notes that a SARS-CoV-2 variant first spotted in South Africa in 2024 has also been detected more frequently in the United States — the picture is not as alarming as the headlines might suggest. Our bodies have seen these opponents before, and they know how to fight back.